Australian (ASX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Jun 21, 2024

Discover Australian Pharmaceuticals & Biotech Growth Stocks that are on the ASX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

89 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

BOT

Botanix Pharmaceuticals
AU$0.369.1%242.9%AU$567.0mn/aPS1297xE120.9%n/a

ACR

Acrux
AU$0.073-5.2%65.9%AU$21.2mn/aPS1.9xE115.3%0%

LGP

Little Green Pharma
AU$0.10-13.0%-39.4%AU$30.2mn/aPS1.2xE110.1%n/a

ARX

Aroa Biosurgery
AU$0.61-1.6%-31.7%AU$211.7mn/aPS3.3xE100.0%n/a

MYX

Mayne Pharma Group
AU$4.61-0.9%17.0%AU$374.1mAU$6.89PS1.2xE99.8%n/a

MVP

Medical Developments International
AU$0.410%-51.5%AU$35.0mAU$3.66PS1xE83.4%0%

TRJ

Trajan Group Holdings
AU$0.963.2%-43.5%AU$146.1mAU$1.15PB1.2xE77.4%n/a

GSS

Genetic Signatures
AU$0.727.4%42.2%AU$156.1mn/aPS9.8xE74.6%n/a

TYP

Tryptamine Therapeutics
AU$0.020%n/aAU$29.3mn/aPE-5.9xE72.5%n/a

BDX

BCAL Diagnostics
AU$0.100%20.7%AU$33.0mn/aPS8.9xE60.0%n/a

OPT

Opthea
AU$0.35-2.7%-33.6%AU$235.3mn/aPS400.9xE59.6%n/a

MSB

Mesoblast
AU$1.03-5.1%-12.8%AU$1.2bAU$1.10PS104.2xE56.7%n/a

IMU

Imugene
AU$0.0591.7%-33.7%AU$431.9mn/aPS28.7xE51.9%n/a

KZA

Kazia Therapeutics
AU$0.08-27.3%-17.5%AU$18.9mn/aPS34068.4xE49.6%n/a

CU6

Clarity Pharmaceuticals
AU$4.60-11.9%557.1%AU$1.4bAU$3.87PS151xE46.0%n/a

PIQ

Proteomics International Laboratories
AU$0.891.7%1.1%AU$115.8mn/aPS38.2xE37.2%n/a

TLX

Telix Pharmaceuticals
AU$18.4411.0%56.5%AU$6.5bAU$18.89PE204.4xE35.7%n/a

CYP

Cynata Therapeutics
AU$0.27-12.9%107.7%AU$48.5mAU$1.22PS20.2xE35.6%n/a

RAD

Radiopharm Theranostics
AU$0.03413.3%-70.4%AU$15.7mn/aPS2.6xE28.5%n/a

PAR

Paradigm Biopharmaceuticals
AU$0.244.3%-72.8%AU$85.8mn/aPS2041.4xE20.4%n/a

IMM

Immutep
AU$0.422.4%50.0%AU$598.3mn/aPS152.2xE18.0%n/a

SNT

Syntara
AU$0.025-13.8%-47.9%AU$29.9mn/aPS1.5xE17.3%n/a

CSL

CSL
AU$293.001.3%3.9%AU$141.6bAU$307.12PE38.1xE14.7%1.2%

CUV

Clinuvel Pharmaceuticals
AU$15.394.0%-11.7%AU$770.8mAU$25.60PE25.6xE13.5%0.3%
Page 1 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.